Park Ha Biological Technology Co., Ltd. revenue by segment BYAH
Park Ha Biological Technology Co., Ltd. splits its revenue into 3 lines in its filings. The largest line in fiscal 2025, which ended Oct 31, 2025 was Franchise Fees at $1.5 million, 60% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2025
Oct 31, 2025
|
FY 2024
Oct 31, 2024
|
|---|---|---|
| Revenue |
3
|
2
|
| Franchise Fees |
2
-9.8%
share 59.8%
|
2
share 70.3%
|
| Products Sales Nonfranchisees |
1
+50.6%
share 21.2%
|
0
share 14.9%
|
| Product Sales Franchisees |
0
+36.1%
share 18.9%
|
0
share 14.8%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. More on our methodology.
Company profile
- Industry
- Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (SIC 2840)
- Listed as
- BYAH (Nasdaq)
- Fiscal year ends
- October 31
- Incorporated in
- China
- Headquarters
- Wuxi City, China
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1986247
Other Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics companies
- PROCTER & GAMBLE Co PG
- Unilever PLC UL
- Ecolab Inc. ECL
- Church & Dwight Co Inc /DE/ CHD
- Stepan Co SCL
- Meiwu Technology Co Ltd WNW
- Longevity Health Holdings, Inc. XAGE
- Orion Bliss Corp. ORIB
All 9 Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.